Global Factor IX Complex Drug Market 2024 by Manufacturers, Regions, Type and Application, Forecast to 2030
Page: 91
Published Date: 13 Jan 2024
Category: Pharma & Healthcare
PDF Download
Get FREE Sample
Customize Request
-
Description
Table of Contents
Table of Figures
Research Methodology
Companies Mentioned
Related Reports
Product Tags
Table of Contents
Table of Figures
Research Methodology
Companies Mentioned
Related Reports
Product Tags
Description
According to our (Global Info Research) latest study, the global Factor IX Complex Drug market size was valued at USD 874.6 million in 2023 and is forecast to a readjusted size of USD 1838.5 million by 2030 with a CAGR of 11.2% during review period.
Prothrombin complex concentrate (PCC), also known as factor IX complex, is a medication made up of blood clotting factors II, IX, and X. Some versions also contain factor VII. It is used to treat and prevent bleeding in hemophilia B if pure factor IX is not available.
The market factors is increasing prescription of anticoagulants, especially warfarin, as well as rising prevalence of bleeding disorders. Additionally, PCC offers various advantages over Fresh-frozen plasma and others, making it a more suitable option for life-threatening conditions. Apart from this, active government support for the use of 4-factor PCC products such as Kcentra and positive recommendations are anticipated to provide considerable momentum to the market.
The Global Info Research report includes an overview of the development of the Factor IX Complex Drug industry chain, the market status of Hemophilia B (Beriplex, Profilnine), Acquired Coagulation Factor Deficiency (Beriplex, Profilnine), and key enterprises in developed and developing market, and analysed the cutting-edge technology, patent, hot applications and market trends of Factor IX Complex Drug.
Regionally, the report analyzes the Factor IX Complex Drug markets in key regions. North America and Europe are experiencing steady growth, driven by government initiatives and increasing consumer awareness. Asia-Pacific, particularly China, leads the global Factor IX Complex Drug market, with robust domestic demand, supportive policies, and a strong manufacturing base.
Key Features:
The report presents comprehensive understanding of the Factor IX Complex Drug market. It provides a holistic view of the industry, as well as detailed insights into individual components and stakeholders. The report analysis market dynamics, trends, challenges, and opportunities within the Factor IX Complex Drug industry.
The report involves analyzing the market at a macro level:
Market Sizing and Segmentation: Report collect data on the overall market size, including the sales quantity (K Units), revenue generated, and market share of different by Type (e.g., Beriplex, Profilnine).
Industry Analysis: Report analyse the broader industry trends, such as government policies and regulations, technological advancements, consumer preferences, and market dynamics. This analysis helps in understanding the key drivers and challenges influencing the Factor IX Complex Drug market.
Regional Analysis: The report involves examining the Factor IX Complex Drug market at a regional or national level. Report analyses regional factors such as government incentives, infrastructure development, economic conditions, and consumer behaviour to identify variations and opportunities within different markets.
Market Projections: Report covers the gathered data and analysis to make future projections and forecasts for the Factor IX Complex Drug market. This may include estimating market growth rates, predicting market demand, and identifying emerging trends.
The report also involves a more granular approach to Factor IX Complex Drug:
Company Analysis: Report covers individual Factor IX Complex Drug manufacturers, suppliers, and other relevant industry players. This analysis includes studying their financial performance, market positioning, product portfolios, partnerships, and strategies.
Consumer Analysis: Report covers data on consumer behaviour, preferences, and attitudes towards Factor IX Complex Drug This may involve surveys, interviews, and analysis of consumer reviews and feedback from different by Application (Hemophilia B, Acquired Coagulation Factor Deficiency).
Technology Analysis: Report covers specific technologies relevant to Factor IX Complex Drug. It assesses the current state, advancements, and potential future developments in Factor IX Complex Drug areas.
Competitive Landscape: By analyzing individual companies, suppliers, and consumers, the report present insights into the competitive landscape of the Factor IX Complex Drug market. This analysis helps understand market share, competitive advantages, and potential areas for differentiation among industry players.
Market Validation: The report involves validating findings and projections through primary research, such as surveys, interviews, and focus groups.
Market Segmentation
Factor IX Complex Drug market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value.
Market segment by Type
Beriplex
Profilnine
Octaplex
Prothromplex
Cofact
Other
Market segment by Application
Hemophilia B
Acquired Coagulation Factor Deficiency
Major players covered
CSL Behring
Grifols
Octapharma
Prothya Biosolutions
Takeda
Market segment by region, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Factor IX Complex Drug product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Factor IX Complex Drug, with price, sales, revenue and global market share of Factor IX Complex Drug from 2019 to 2024.
Chapter 3, the Factor IX Complex Drug competitive situation, sales quantity, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Factor IX Complex Drug breakdown data are shown at the regional level, to show the sales quantity, consumption value and growth by regions, from 2019 to 2030.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2019 to 2030.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value and market share for key countries in the world, from 2017 to 2023.and Factor IX Complex Drug market forecast, by regions, type and application, with sales and revenue, from 2025 to 2030.
Chapter 12, market dynamics, drivers, restraints, trends and Porters Five Forces analysis.
Chapter 13, the key raw materials and key suppliers, and industry chain of Factor IX Complex Drug.
Chapter 14 and 15, to describe Factor IX Complex Drug sales channel, distributors, customers, research findings and conclusion.
Table of Contents
1 Market Overview
1.1 Product Overview and Scope of Factor IX Complex Drug
1.2 Market Estimation Caveats and Base Year
1.3 Market Analysis by Type
1.3.1 Overview: Global Factor IX Complex Drug Consumption Value by Type: 2019 Versus 2023 Versus 2030
1.3.2 Beriplex
1.3.3 Profilnine
1.3.4 Octaplex
1.3.5 Prothromplex
1.3.6 Cofact
1.3.7 Other
1.4 Market Analysis by Application
1.4.1 Overview: Global Factor IX Complex Drug Consumption Value by Application: 2019 Versus 2023 Versus 2030
1.4.2 Hemophilia B
1.4.3 Acquired Coagulation Factor Deficiency
1.5 Global Factor IX Complex Drug Market Size & Forecast
1.5.1 Global Factor IX Complex Drug Consumption Value (2019 & 2023 & 2030)
1.5.2 Global Factor IX Complex Drug Sales Quantity (2019-2030)
1.5.3 Global Factor IX Complex Drug Average Price (2019-2030)
2.1 CSL Behring
2.1.1 CSL Behring Details
2.1.2 CSL Behring Major Business
2.1.3 CSL Behring Factor IX Complex Drug Product and Services
2.1.4 CSL Behring Factor IX Complex Drug Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.1.5 CSL Behring Recent Developments/Updates
2.2 Grifols
2.2.1 Grifols Details
2.2.2 Grifols Major Business
2.2.3 Grifols Factor IX Complex Drug Product and Services
2.2.4 Grifols Factor IX Complex Drug Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.2.5 Grifols Recent Developments/Updates
2.3 Octapharma
2.3.1 Octapharma Details
2.3.2 Octapharma Major Business
2.3.3 Octapharma Factor IX Complex Drug Product and Services
2.3.4 Octapharma Factor IX Complex Drug Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.3.5 Octapharma Recent Developments/Updates
2.4 Prothya Biosolutions
2.4.1 Prothya Biosolutions Details
2.4.2 Prothya Biosolutions Major Business
2.4.3 Prothya Biosolutions Factor IX Complex Drug Product and Services
2.4.4 Prothya Biosolutions Factor IX Complex Drug Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.4.5 Prothya Biosolutions Recent Developments/Updates
2.5 Takeda
2.5.1 Takeda Details
2.5.2 Takeda Major Business
2.5.3 Takeda Factor IX Complex Drug Product and Services
2.5.4 Takeda Factor IX Complex Drug Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.5.5 Takeda Recent Developments/Updates
3.1 Global Factor IX Complex Drug Sales Quantity by Manufacturer (2019-2024)
3.2 Global Factor IX Complex Drug Revenue by Manufacturer (2019-2024)
3.3 Global Factor IX Complex Drug Average Price by Manufacturer (2019-2024)
3.4 Market Share Analysis (2023)
3.4.1 Producer Shipments of Factor IX Complex Drug by Manufacturer Revenue ($MM) and Market Share (%): 2023
3.4.2 Top 3 Factor IX Complex Drug Manufacturer Market Share in 2023
3.4.2 Top 6 Factor IX Complex Drug Manufacturer Market Share in 2023
3.5 Factor IX Complex Drug Market: Overall Company Footprint Analysis
3.5.1 Factor IX Complex Drug Market: Region Footprint
3.5.2 Factor IX Complex Drug Market: Company Product Type Footprint
3.5.3 Factor IX Complex Drug Market: Company Product Application Footprint
3.6 New Market Entrants and Barriers to Market Entry
3.7 Mergers, Acquisition, Agreements, and Collaborations
4.1 Global Factor IX Complex Drug Market Size by Region
4.1.1 Global Factor IX Complex Drug Sales Quantity by Region (2019-2030)
4.1.2 Global Factor IX Complex Drug Consumption Value by Region (2019-2030)
4.1.3 Global Factor IX Complex Drug Average Price by Region (2019-2030)
4.2 North America Factor IX Complex Drug Consumption Value (2019-2030)
4.3 Europe Factor IX Complex Drug Consumption Value (2019-2030)
4.4 Asia-Pacific Factor IX Complex Drug Consumption Value (2019-2030)
4.5 South America Factor IX Complex Drug Consumption Value (2019-2030)
4.6 Middle East and Africa Factor IX Complex Drug Consumption Value (2019-2030)
5.1 Global Factor IX Complex Drug Sales Quantity by Type (2019-2030)
5.2 Global Factor IX Complex Drug Consumption Value by Type (2019-2030)
5.3 Global Factor IX Complex Drug Average Price by Type (2019-2030)
6.1 Global Factor IX Complex Drug Sales Quantity by Application (2019-2030)
6.2 Global Factor IX Complex Drug Consumption Value by Application (2019-2030)
6.3 Global Factor IX Complex Drug Average Price by Application (2019-2030)
7.1 North America Factor IX Complex Drug Sales Quantity by Type (2019-2030)
7.2 North America Factor IX Complex Drug Sales Quantity by Application (2019-2030)
7.3 North America Factor IX Complex Drug Market Size by Country
7.3.1 North America Factor IX Complex Drug Sales Quantity by Country (2019-2030)
7.3.2 North America Factor IX Complex Drug Consumption Value by Country (2019-2030)
7.3.3 United States Market Size and Forecast (2019-2030)
7.3.4 Canada Market Size and Forecast (2019-2030)
7.3.5 Mexico Market Size and Forecast (2019-2030)
8.1 Europe Factor IX Complex Drug Sales Quantity by Type (2019-2030)
8.2 Europe Factor IX Complex Drug Sales Quantity by Application (2019-2030)
8.3 Europe Factor IX Complex Drug Market Size by Country
8.3.1 Europe Factor IX Complex Drug Sales Quantity by Country (2019-2030)
8.3.2 Europe Factor IX Complex Drug Consumption Value by Country (2019-2030)
8.3.3 Germany Market Size and Forecast (2019-2030)
8.3.4 France Market Size and Forecast (2019-2030)
8.3.5 United Kingdom Market Size and Forecast (2019-2030)
8.3.6 Russia Market Size and Forecast (2019-2030)
8.3.7 Italy Market Size and Forecast (2019-2030)
9.1 Asia-Pacific Factor IX Complex Drug Sales Quantity by Type (2019-2030)
9.2 Asia-Pacific Factor IX Complex Drug Sales Quantity by Application (2019-2030)
9.3 Asia-Pacific Factor IX Complex Drug Market Size by Region
9.3.1 Asia-Pacific Factor IX Complex Drug Sales Quantity by Region (2019-2030)
9.3.2 Asia-Pacific Factor IX Complex Drug Consumption Value by Region (2019-2030)
9.3.3 China Market Size and Forecast (2019-2030)
9.3.4 Japan Market Size and Forecast (2019-2030)
9.3.5 Korea Market Size and Forecast (2019-2030)
9.3.6 India Market Size and Forecast (2019-2030)
9.3.7 Southeast Asia Market Size and Forecast (2019-2030)
9.3.8 Australia Market Size and Forecast (2019-2030)
10.1 South America Factor IX Complex Drug Sales Quantity by Type (2019-2030)
10.2 South America Factor IX Complex Drug Sales Quantity by Application (2019-2030)
10.3 South America Factor IX Complex Drug Market Size by Country
10.3.1 South America Factor IX Complex Drug Sales Quantity by Country (2019-2030)
10.3.2 South America Factor IX Complex Drug Consumption Value by Country (2019-2030)
10.3.3 Brazil Market Size and Forecast (2019-2030)
10.3.4 Argentina Market Size and Forecast (2019-2030)
11.1 Middle East & Africa Factor IX Complex Drug Sales Quantity by Type (2019-2030)
11.2 Middle East & Africa Factor IX Complex Drug Sales Quantity by Application (2019-2030)
11.3 Middle East & Africa Factor IX Complex Drug Market Size by Country
11.3.1 Middle East & Africa Factor IX Complex Drug Sales Quantity by Country (2019-2030)
11.3.2 Middle East & Africa Factor IX Complex Drug Consumption Value by Country (2019-2030)
11.3.3 Turkey Market Size and Forecast (2019-2030)
11.3.4 Egypt Market Size and Forecast (2019-2030)
11.3.5 Saudi Arabia Market Size and Forecast (2019-2030)
11.3.6 South Africa Market Size and Forecast (2019-2030)
12.1 Factor IX Complex Drug Market Drivers
12.2 Factor IX Complex Drug Market Restraints
12.3 Factor IX Complex Drug Trends Analysis
12.4 Porters Five Forces Analysis
12.4.1 Threat of New Entrants
12.4.2 Bargaining Power of Suppliers
12.4.3 Bargaining Power of Buyers
12.4.4 Threat of Substitutes
12.4.5 Competitive Rivalry
13.1 Raw Material of Factor IX Complex Drug and Key Manufacturers
13.2 Manufacturing Costs Percentage of Factor IX Complex Drug
13.3 Factor IX Complex Drug Production Process
13.4 Factor IX Complex Drug Industrial Chain
14.1 Sales Channel
14.1.1 Direct to End-User
14.1.2 Distributors
14.2 Factor IX Complex Drug Typical Distributors
14.3 Factor IX Complex Drug Typical Customers
16.1 Methodology
16.2 Research Process and Data Source
16.3 Disclaimer
Table of Figures
List of Tables
Table 1. Global Factor IX Complex Drug Consumption Value by Type, (USD Million), 2019 & 2023 & 2030
Table 2. Global Factor IX Complex Drug Consumption Value by Application, (USD Million), 2019 & 2023 & 2030
Table 3. CSL Behring Basic Information, Manufacturing Base and Competitors
Table 4. CSL Behring Major Business
Table 5. CSL Behring Factor IX Complex Drug Product and Services
Table 6. CSL Behring Factor IX Complex Drug Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 7. CSL Behring Recent Developments/Updates
Table 8. Grifols Basic Information, Manufacturing Base and Competitors
Table 9. Grifols Major Business
Table 10. Grifols Factor IX Complex Drug Product and Services
Table 11. Grifols Factor IX Complex Drug Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 12. Grifols Recent Developments/Updates
Table 13. Octapharma Basic Information, Manufacturing Base and Competitors
Table 14. Octapharma Major Business
Table 15. Octapharma Factor IX Complex Drug Product and Services
Table 16. Octapharma Factor IX Complex Drug Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 17. Octapharma Recent Developments/Updates
Table 18. Prothya Biosolutions Basic Information, Manufacturing Base and Competitors
Table 19. Prothya Biosolutions Major Business
Table 20. Prothya Biosolutions Factor IX Complex Drug Product and Services
Table 21. Prothya Biosolutions Factor IX Complex Drug Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 22. Prothya Biosolutions Recent Developments/Updates
Table 23. Takeda Basic Information, Manufacturing Base and Competitors
Table 24. Takeda Major Business
Table 25. Takeda Factor IX Complex Drug Product and Services
Table 26. Takeda Factor IX Complex Drug Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 27. Takeda Recent Developments/Updates
Table 28. Global Factor IX Complex Drug Sales Quantity by Manufacturer (2019-2024) & (K Units)
Table 29. Global Factor IX Complex Drug Revenue by Manufacturer (2019-2024) & (USD Million)
Table 30. Global Factor IX Complex Drug Average Price by Manufacturer (2019-2024) & (US$/Unit)
Table 31. Market Position of Manufacturers in Factor IX Complex Drug, (Tier 1, Tier 2, and Tier 3), Based on Consumption Value in 2023
Table 32. Head Office and Factor IX Complex Drug Production Site of Key Manufacturer
Table 33. Factor IX Complex Drug Market: Company Product Type Footprint
Table 34. Factor IX Complex Drug Market: Company Product Application Footprint
Table 35. Factor IX Complex Drug New Market Entrants and Barriers to Market Entry
Table 36. Factor IX Complex Drug Mergers, Acquisition, Agreements, and Collaborations
Table 37. Global Factor IX Complex Drug Sales Quantity by Region (2019-2024) & (K Units)
Table 38. Global Factor IX Complex Drug Sales Quantity by Region (2025-2030) & (K Units)
Table 39. Global Factor IX Complex Drug Consumption Value by Region (2019-2024) & (USD Million)
Table 40. Global Factor IX Complex Drug Consumption Value by Region (2025-2030) & (USD Million)
Table 41. Global Factor IX Complex Drug Average Price by Region (2019-2024) & (US$/Unit)
Table 42. Global Factor IX Complex Drug Average Price by Region (2025-2030) & (US$/Unit)
Table 43. Global Factor IX Complex Drug Sales Quantity by Type (2019-2024) & (K Units)
Table 44. Global Factor IX Complex Drug Sales Quantity by Type (2025-2030) & (K Units)
Table 45. Global Factor IX Complex Drug Consumption Value by Type (2019-2024) & (USD Million)
Table 46. Global Factor IX Complex Drug Consumption Value by Type (2025-2030) & (USD Million)
Table 47. Global Factor IX Complex Drug Average Price by Type (2019-2024) & (US$/Unit)
Table 48. Global Factor IX Complex Drug Average Price by Type (2025-2030) & (US$/Unit)
Table 49. Global Factor IX Complex Drug Sales Quantity by Application (2019-2024) & (K Units)
Table 50. Global Factor IX Complex Drug Sales Quantity by Application (2025-2030) & (K Units)
Table 51. Global Factor IX Complex Drug Consumption Value by Application (2019-2024) & (USD Million)
Table 52. Global Factor IX Complex Drug Consumption Value by Application (2025-2030) & (USD Million)
Table 53. Global Factor IX Complex Drug Average Price by Application (2019-2024) & (US$/Unit)
Table 54. Global Factor IX Complex Drug Average Price by Application (2025-2030) & (US$/Unit)
Table 55. North America Factor IX Complex Drug Sales Quantity by Type (2019-2024) & (K Units)
Table 56. North America Factor IX Complex Drug Sales Quantity by Type (2025-2030) & (K Units)
Table 57. North America Factor IX Complex Drug Sales Quantity by Application (2019-2024) & (K Units)
Table 58. North America Factor IX Complex Drug Sales Quantity by Application (2025-2030) & (K Units)
Table 59. North America Factor IX Complex Drug Sales Quantity by Country (2019-2024) & (K Units)
Table 60. North America Factor IX Complex Drug Sales Quantity by Country (2025-2030) & (K Units)
Table 61. North America Factor IX Complex Drug Consumption Value by Country (2019-2024) & (USD Million)
Table 62. North America Factor IX Complex Drug Consumption Value by Country (2025-2030) & (USD Million)
Table 63. Europe Factor IX Complex Drug Sales Quantity by Type (2019-2024) & (K Units)
Table 64. Europe Factor IX Complex Drug Sales Quantity by Type (2025-2030) & (K Units)
Table 65. Europe Factor IX Complex Drug Sales Quantity by Application (2019-2024) & (K Units)
Table 66. Europe Factor IX Complex Drug Sales Quantity by Application (2025-2030) & (K Units)
Table 67. Europe Factor IX Complex Drug Sales Quantity by Country (2019-2024) & (K Units)
Table 68. Europe Factor IX Complex Drug Sales Quantity by Country (2025-2030) & (K Units)
Table 69. Europe Factor IX Complex Drug Consumption Value by Country (2019-2024) & (USD Million)
Table 70. Europe Factor IX Complex Drug Consumption Value by Country (2025-2030) & (USD Million)
Table 71. Asia-Pacific Factor IX Complex Drug Sales Quantity by Type (2019-2024) & (K Units)
Table 72. Asia-Pacific Factor IX Complex Drug Sales Quantity by Type (2025-2030) & (K Units)
Table 73. Asia-Pacific Factor IX Complex Drug Sales Quantity by Application (2019-2024) & (K Units)
Table 74. Asia-Pacific Factor IX Complex Drug Sales Quantity by Application (2025-2030) & (K Units)
Table 75. Asia-Pacific Factor IX Complex Drug Sales Quantity by Region (2019-2024) & (K Units)
Table 76. Asia-Pacific Factor IX Complex Drug Sales Quantity by Region (2025-2030) & (K Units)
Table 77. Asia-Pacific Factor IX Complex Drug Consumption Value by Region (2019-2024) & (USD Million)
Table 78. Asia-Pacific Factor IX Complex Drug Consumption Value by Region (2025-2030) & (USD Million)
Table 79. South America Factor IX Complex Drug Sales Quantity by Type (2019-2024) & (K Units)
Table 80. South America Factor IX Complex Drug Sales Quantity by Type (2025-2030) & (K Units)
Table 81. South America Factor IX Complex Drug Sales Quantity by Application (2019-2024) & (K Units)
Table 82. South America Factor IX Complex Drug Sales Quantity by Application (2025-2030) & (K Units)
Table 83. South America Factor IX Complex Drug Sales Quantity by Country (2019-2024) & (K Units)
Table 84. South America Factor IX Complex Drug Sales Quantity by Country (2025-2030) & (K Units)
Table 85. South America Factor IX Complex Drug Consumption Value by Country (2019-2024) & (USD Million)
Table 86. South America Factor IX Complex Drug Consumption Value by Country (2025-2030) & (USD Million)
Table 87. Middle East & Africa Factor IX Complex Drug Sales Quantity by Type (2019-2024) & (K Units)
Table 88. Middle East & Africa Factor IX Complex Drug Sales Quantity by Type (2025-2030) & (K Units)
Table 89. Middle East & Africa Factor IX Complex Drug Sales Quantity by Application (2019-2024) & (K Units)
Table 90. Middle East & Africa Factor IX Complex Drug Sales Quantity by Application (2025-2030) & (K Units)
Table 91. Middle East & Africa Factor IX Complex Drug Sales Quantity by Region (2019-2024) & (K Units)
Table 92. Middle East & Africa Factor IX Complex Drug Sales Quantity by Region (2025-2030) & (K Units)
Table 93. Middle East & Africa Factor IX Complex Drug Consumption Value by Region (2019-2024) & (USD Million)
Table 94. Middle East & Africa Factor IX Complex Drug Consumption Value by Region (2025-2030) & (USD Million)
Table 95. Factor IX Complex Drug Raw Material
Table 96. Key Manufacturers of Factor IX Complex Drug Raw Materials
Table 97. Factor IX Complex Drug Typical Distributors
Table 98. Factor IX Complex Drug Typical Customers
List of Figures
Figure 1. Factor IX Complex Drug Picture
Figure 2. Global Factor IX Complex Drug Consumption Value by Type, (USD Million), 2019 & 2023 & 2030
Figure 3. Global Factor IX Complex Drug Consumption Value Market Share by Type in 2023
Figure 4. Beriplex Examples
Figure 5. Profilnine Examples
Figure 6. Octaplex Examples
Figure 7. Prothromplex Examples
Figure 8. Cofact Examples
Figure 9. Other Examples
Figure 10. Global Factor IX Complex Drug Consumption Value by Application, (USD Million), 2019 & 2023 & 2030
Figure 11. Global Factor IX Complex Drug Consumption Value Market Share by Application in 2023
Figure 12. Hemophilia B Examples
Figure 13. Acquired Coagulation Factor Deficiency Examples
Figure 14. Global Factor IX Complex Drug Consumption Value, (USD Million): 2019 & 2023 & 2030
Figure 15. Global Factor IX Complex Drug Consumption Value and Forecast (2019-2030) & (USD Million)
Figure 16. Global Factor IX Complex Drug Sales Quantity (2019-2030) & (K Units)
Figure 17. Global Factor IX Complex Drug Average Price (2019-2030) & (US$/Unit)
Figure 18. Global Factor IX Complex Drug Sales Quantity Market Share by Manufacturer in 2023
Figure 19. Global Factor IX Complex Drug Consumption Value Market Share by Manufacturer in 2023
Figure 20. Producer Shipments of Factor IX Complex Drug by Manufacturer Sales Quantity ($MM) and Market Share (%): 2023
Figure 21. Top 3 Factor IX Complex Drug Manufacturer (Consumption Value) Market Share in 2023
Figure 22. Top 6 Factor IX Complex Drug Manufacturer (Consumption Value) Market Share in 2023
Figure 23. Global Factor IX Complex Drug Sales Quantity Market Share by Region (2019-2030)
Figure 24. Global Factor IX Complex Drug Consumption Value Market Share by Region (2019-2030)
Figure 25. North America Factor IX Complex Drug Consumption Value (2019-2030) & (USD Million)
Figure 26. Europe Factor IX Complex Drug Consumption Value (2019-2030) & (USD Million)
Figure 27. Asia-Pacific Factor IX Complex Drug Consumption Value (2019-2030) & (USD Million)
Figure 28. South America Factor IX Complex Drug Consumption Value (2019-2030) & (USD Million)
Figure 29. Middle East & Africa Factor IX Complex Drug Consumption Value (2019-2030) & (USD Million)
Figure 30. Global Factor IX Complex Drug Sales Quantity Market Share by Type (2019-2030)
Figure 31. Global Factor IX Complex Drug Consumption Value Market Share by Type (2019-2030)
Figure 32. Global Factor IX Complex Drug Average Price by Type (2019-2030) & (US$/Unit)
Figure 33. Global Factor IX Complex Drug Sales Quantity Market Share by Application (2019-2030)
Figure 34. Global Factor IX Complex Drug Consumption Value Market Share by Application (2019-2030)
Figure 35. Global Factor IX Complex Drug Average Price by Application (2019-2030) & (US$/Unit)
Figure 36. North America Factor IX Complex Drug Sales Quantity Market Share by Type (2019-2030)
Figure 37. North America Factor IX Complex Drug Sales Quantity Market Share by Application (2019-2030)
Figure 38. North America Factor IX Complex Drug Sales Quantity Market Share by Country (2019-2030)
Figure 39. North America Factor IX Complex Drug Consumption Value Market Share by Country (2019-2030)
Figure 40. United States Factor IX Complex Drug Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 41. Canada Factor IX Complex Drug Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 42. Mexico Factor IX Complex Drug Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 43. Europe Factor IX Complex Drug Sales Quantity Market Share by Type (2019-2030)
Figure 44. Europe Factor IX Complex Drug Sales Quantity Market Share by Application (2019-2030)
Figure 45. Europe Factor IX Complex Drug Sales Quantity Market Share by Country (2019-2030)
Figure 46. Europe Factor IX Complex Drug Consumption Value Market Share by Country (2019-2030)
Figure 47. Germany Factor IX Complex Drug Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 48. France Factor IX Complex Drug Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 49. United Kingdom Factor IX Complex Drug Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 50. Russia Factor IX Complex Drug Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 51. Italy Factor IX Complex Drug Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 52. Asia-Pacific Factor IX Complex Drug Sales Quantity Market Share by Type (2019-2030)
Figure 53. Asia-Pacific Factor IX Complex Drug Sales Quantity Market Share by Application (2019-2030)
Figure 54. Asia-Pacific Factor IX Complex Drug Sales Quantity Market Share by Region (2019-2030)
Figure 55. Asia-Pacific Factor IX Complex Drug Consumption Value Market Share by Region (2019-2030)
Figure 56. China Factor IX Complex Drug Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 57. Japan Factor IX Complex Drug Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 58. Korea Factor IX Complex Drug Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 59. India Factor IX Complex Drug Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 60. Southeast Asia Factor IX Complex Drug Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 61. Australia Factor IX Complex Drug Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 62. South America Factor IX Complex Drug Sales Quantity Market Share by Type (2019-2030)
Figure 63. South America Factor IX Complex Drug Sales Quantity Market Share by Application (2019-2030)
Figure 64. South America Factor IX Complex Drug Sales Quantity Market Share by Country (2019-2030)
Figure 65. South America Factor IX Complex Drug Consumption Value Market Share by Country (2019-2030)
Figure 66. Brazil Factor IX Complex Drug Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 67. Argentina Factor IX Complex Drug Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 68. Middle East & Africa Factor IX Complex Drug Sales Quantity Market Share by Type (2019-2030)
Figure 69. Middle East & Africa Factor IX Complex Drug Sales Quantity Market Share by Application (2019-2030)
Figure 70. Middle East & Africa Factor IX Complex Drug Sales Quantity Market Share by Region (2019-2030)
Figure 71. Middle East & Africa Factor IX Complex Drug Consumption Value Market Share by Region (2019-2030)
Figure 72. Turkey Factor IX Complex Drug Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 73. Egypt Factor IX Complex Drug Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 74. Saudi Arabia Factor IX Complex Drug Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 75. South Africa Factor IX Complex Drug Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 76. Factor IX Complex Drug Market Drivers
Figure 77. Factor IX Complex Drug Market Restraints
Figure 78. Factor IX Complex Drug Market Trends
Figure 79. Porters Five Forces Analysis
Figure 80. Manufacturing Cost Structure Analysis of Factor IX Complex Drug in 2023
Figure 81. Manufacturing Process Analysis of Factor IX Complex Drug
Figure 82. Factor IX Complex Drug Industrial Chain
Figure 83. Sales Quantity Channel: Direct to End-User vs Distributors
Figure 84. Direct Channel Pros & Cons
Figure 85. Indirect Channel Pros & Cons
Figure 86. Methodology
Figure 87. Research Process and Data Source
Research Methodology
Client Requirements
Review and analyze client requirements
Discussion of all the project requirements and queries
Flexibility Check
Project Feasibility Analysis
Finalizing tentative research programme
Structuring project proposal with scope, timeline, and costs
Analyzing Market Dynamics
Determination of key drivers, restraints, challenge, and opportunity
Identifies market needs and trends
Market Size Estimation & Forecast
Estimation of historical data based on secondary and primary data
Anticipating market recast by assigning weightage to market forces (drivers, restraints, opportunities)
Freezing historical and forecast market size estimations based on evolution, trends, outlook, and strategies
Consideration of geography, region-specific product/service demand for region segments
Consideration of product utilization rates, product demand outlook for segments by application or end-user.
Data Source
Secondary Source
Data collections from annual reports, presentations,associations, journals, analyst reports,
paid database, press releases, blogs, newsletters,and GIR repositories.
Primary Source
Research discussion with manufacturers, distributors, suppliers, end user, industry experts
to verify insights.
Validation
and
triangulation of
secondary and primary source.
Collection of data
Cumulating and collating the essential qualitative and quantitative data
Generation of report in client requested format by research analysts
Reviews by expert analysts
Final quality check
Clarifying queries
Receiving feedback
Ensuring satisfaction
01 Identification of data
This step involves identification of several primary and secondary data research sources, including Global Info Research's internal data sources. The primary sources consist of in-depth discussions and interviews with policy makers, industry experts, and data evaluators, whereas secondary sources include a thorough study of market journals, press releases, annual reports, and government and non-government agencies websites.
-
02 Evaluation of Market Dynamic
This phase includes a detailed evaluation of several factors that are likely to affect the market dynamics. It involves a comprehensive assessment of major market pain points, drivers, and trends. It also comprises a detailed study of research plans and methodology.
-
03 Collection of Data
This process consists of gathering data, accessing proprietary databases, and reaching out to key industry participants that operate in the market across the value chain. It also involves studying several patterns in the historical data and comparing it with the current scenario.
-
04 Collaboration of Data
This stage involves the validation of data and arrival at actual statistics, and evolution of the market over the years. It entails the study and analyzes various segments and verticals of the market. An impact analysis is also performed to observe which factors will affect the market in the next few years.
05 Verification and Analysis
This is the final stage, which involves both quantity and quality checks. Although the process of data verification is an integral part of the research process, all data points and statistics and figures are re-checked to uphold their authenticity and validity.
Companies Mentioned
CSL Behring Grifols Octapharma Prothya Biosolutions Takeda
Related Reports
07 Aug 2023
Pharma & Healthcare
Purchase Options
Add To Cart
Buy Now
Popular Product Keywords
- We Provide Professional, Accurate Market Analysis to Help You Stay Ahead of Your Competition.Speak to our analyst >>
Our Clients
What We Can Provide?
With better results and higher quality products,Our professional reports can achieve four things:
Insight into the industry market information
Analyze market development needs
Prospects for future development
Develop industry investment strategy
- Digging deeper into global industry information and providing market strategies.Contact Us >>
